Article

Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)

Ellie Chabi, MD, therapeutic area head for Glaucoma & Neuroprotection, lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, shares insight on the company's role in the panel discussion focusing on new developments and discoveries in the glaucoma space during the 2020 Glaucoma 360 annual meeting in San Francisco, California.
 


See more Glaucoma 360 coverage here 

 

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.